Fertility-preserving surgical procedures for patients with gynecologic malignancies

Clinical Obstetrics and Gynecology

Volumn 53, Issue 4, 2010, Pages 804-814

  Rasool, Nabila ^a   Rose, Peter G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

fertility preservation; fertility preserving surgical techniques; gynecologic malignancies

Indexed keywords

LEVONORGESTREL; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PROGESTERONE;

AGE DISTRIBUTION; CANCER HORMONE THERAPY; CONSERVATIVE TREATMENT; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE FERTILITY; GERM CELL TUMOR; GYNECOLOGIC CANCER; GYNECOLOGIC SURGERY; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; OVARIAN PRESERVATION; OVARIAN TRANSPOSITION; OVARIECTOMY; OVARY CANCER; PRESERVATION; RADICAL TRACHELECTOMY; REVIEW; SEX CORD TUMOR; SURGICAL TECHNIQUE; TROPHOBLASTIC TUMOR; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION;

ANTINEOPLASTIC AGENTS, HORMONAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CONIZATION; FEMALE; FERTILITY; GENITAL NEOPLASMS, FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INTRAUTERINE DEVICES, MEDICATED; NEOPLASM INVASIVENESS; NEOPLASMS, GERM CELL AND EMBRYONAL; PREGNANCY; PROGESTERONE; PROGESTINS; SEX CORD-GONADAL STROMAL TUMORS; TROPHOBLASTIC NEOPLASMS;

EID: 78349250583     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181f97d02     Document Type: Review

References (37)

1. Surveillance, Epidemiology and End Results. http://seer.cancer.gov. (Accessed January 16, 2010).
2. Morris M, Mitchell MF, Silva EG, et al. Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol. 1993;51: 193-196.
3. Gadducci A, Sartori E, Maggino T, et al. The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperative Task Force (CTF) study. Eur J Gynaecol Oncol. 2003;24:513-516.
4. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367:489-498.
5. McHale MT, Le TD, Burger RA, et al. Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix. Obstet Gynecol. 2001;98(5 Pt1): 726-731.
6. Schorge JO, Lee KR, Sheets EE. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report. Gynecol Oncol. 2000;78:217-220.
7. Plante M. Vaginal radical trachlectomy: an update. Gynecol Oncol. 2008;111: S105-S110.
8. Leblanc E, Narducci F, Ferron G, et al. Indications and teaching of fertility preservation in the surgical management of gynecologic malignancies: European perspective. Gynecol Oncol. 2009;114(2 suppl):S32-S36.
9. Liou WS, Yap OW, Chan JK, et al. Innovations in fertility preservation for patients with gynecologic cancers. Fertil Steril. 2005;84:1561-1573.
10. Dargent D, Franzosi F, Ansquer Y, et al. Extended trachlectomy relapse: plea for patient involvement in the medical decision. Bull Cancer. 2002;89:1027-1030.
11. Covens A, Shaw P, Murphy J, et al. Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix? Cancer. 1999;86:2273-2279.
12. Bernardini M, Barrett J, Seaward G, et al. Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gyne-col. 2003;189:1378-1382.
13. Shepherd JH, Mould T, Oram DH. Radical trachelectomy in early stage carcinoma of the cervix: outcome as judged by recurrence and fertility rates. BJOG. 2001;108:882-885.
14. Nishio H, Fujii T, Kameyama K, et al. Abdominal radical trachelectomy as a fertility-sparing procedure in women with earl-stage cervical cancer in a series of 61 women. Gynecol Oncol. 2009;115: 51-55.
15. Burnett AF, Stone PJ, Duckworth LA, et al. Robotic radical trachelctomy for preservation of fertility in early cervical cancer: case series and description of technique. J Minim Invasive Gynecol. 2009;16:569-572.
16. Morice P, Juncker L, Rey A, et al. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril. 2000;74: 743-748.
17. Zinger M, Liu JH, Husseinzadeh N, et al. Successful surrogate pregnancy after ovarian transposition, pelvic irradiation and hysterectomy. J Reprod Med. 2004; 49:573-574.
18. Agorastos T, Zafrakas M, Mastominas M. Long-term follow-up after cervical cancer treatment and subsequent successful surrogate pregnancy. Reprod Biomed Online. 2009;19:250-251.
19. Manfredi R, Mirk P, Maresca G, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology. 2004;23: 372-378.
20. Vasconcelos C, Felix A, Cunha TM. Pre-operative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation. J Obstet Gynaecol. 2007; 27:65-70.
21. Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106:812-819.
22. Ushijima K, Hideaki Y, Yoshikawa H, et al. Multicenter phase II study of fertility-sparing treatment with medroxyproges-terone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol. 2007;25:2798-2803.
23. Ramirez PT, FrumovitzM, BodurkaDC, et al. Hormonal therapy for the management of grade 1 endometrial adenocarci-noma: a literature review. Gynecol Oncol. 2004;95:133-138.
24. Montz FJ, Bristow RE, Bovicelli A, et al. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol. 2002;186:651-657.
25. Orbo A, Arnes M, Hancke C, et al. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecol Oncol. 2008; 111:68-73.
26. Mazzon I, Corrado G, Masciullo V, et al. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril. 2009;93: 1286-1289.
27. Rose PG, Mendelsohn G, Kornbluth I. Hysteroscopic dissemination of endome-trial carcinoma. Gynecol Oncol. 1998;71: 145-146.
28. Lee TS, Kim JW, Cho CH, et al. Ovarian preservation during the surgical treatment of early stage endometrial cancer: a nation-wide study conducted by the Korean Gynecologic Oncology Group. Gynecol Oncol. 2009;115:26-31.
29. Wright JD, Buck AM, Shah M, et al. Safety of ovarian preservation in preme-nopausal women with endometrial cancer. J Clin Oncol. 2009;27:1214-1219.
30. Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002;87:1-7.
31. Zanetta G, Chiari S, Rota S, et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol. 1997;104:1030-1035.
32. Park JY, Kim DY, Suh DS, et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: onco-logic safety and reproductive outcomes. Gynecol Oncol. 2008;110:345-353.
33. Tinelli R, Tinelli A, Tinelli FG, et al. Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol. 2006;100:185-191.
34. Zanetta G, Rota S, Chiari S, et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 2001; 19:2658-2664.
35. Morice P, Camatte S, El Hassan J, et al. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril. 2001;75: 92-96.
36. Tangir J, Zeterman D, Ma W, et al. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol. 2003;101:251-257.
37. Zanetta G, Bonazzi C, Cantu M, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol. 2001;19: 1015-1020.